Effects of a Plyometric Training Program on Youths With Different Biological Maturity in Sport

May 29, 2026 updated by: Jakub Krejci, Palacky University

A Randomized Controlled Trial Evaluating the Effect of Plyometric Training on Power, Speed, and Agility in Sport-active Boys With Different Biological Maturity

This randomized controlled trial aims to assess the effectiveness of a 12-week plyometric training regimen on improving power, speed, and agility among boys aged 10 to 18 years who are actively engaged in sports and exhibit differing levels of biological maturity. The study seeks to determine how maturation affects the responsiveness to the training program, potentially influencing future sports training approaches for young athletes.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

The main objective of this project is to assess the impact of a plyometric program on power, speed, agility, reactive strength index and stiffness in male athletes of different levels of maturation. The study takes the form of a short-term experiment (12 weeks), involving 30 young athletes with a minimum of two years of experience in systematic sports training. Participants are divided into an experimental group and a control group. The experimental group undergoes a 12-week plyometric training program, implemented twice a week within training sessions immediately following warm-ups. The control group engages in technical-tactical exercises. The program is developed by the authors of the research project based on current knowledge and requirements for creating an effective and safe plyometric program. Randomization is performed using a computer random generator. Participants undergo two testing sessions: one prior to the training intervention and the other one week after its completion. Age, height, weight, and body composition are measured using a personal scale with an integrated stadiometer. Tests include a 30-m sprint, countermovement jump, broad jump, unilateral triple jump, drop jump (reactive strength index), 20 submaximal vertical jumps (lower limb stiffness), BlazePod reaction test, and 505 agility test. The maturity status of the participants is evaluated using the Mirwald method and is used as a covariate in the subsequent statistical analysis. Findings of this research may provide crucial insights for targeted integration of plyometric methods during the developmental and maturation phases of young athletes.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
38

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Contact Backup

Study Locations

  • Czechia
      • Olomouc, Czechia, 77111
        • Palacky University, Faculty of Physical Culture

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Minimum of 2 years of organized sports participation.
  • Good health as confirmed by a pre-study medical screening.
  • Signed informed consent from the legal representative and verbal assent from the participant.

Exclusion Criteria:

  • Any serious lower limb injury in the past 6 months.
  • Any current or historical mental health disorders.
  • Any condition deemed by the medical screener as a contraindication to vigorous physical activity.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Plyometric training
Plyometric training program for 12 weeks.
Other: Plyometric training
Participants undergo a plyometric training program. The plyometric training consists of exercises in the horizontal, lateral, and vertical directions of movement. Exercises are progressively focused on maximal performance with short ground contact (<250 ms). The training sessions are twice per week.
Active Comparator: Control training
Regular training program for 12 weeks.
Other: Control training
Participants continues their regular sports activities without additional plyometric training. The training sessions are twice per week.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Vertical jump height
Time Frame: 12 weeks
The vertical jump is performed on AMTI OR6-7-1000 force platform (Advanced Mechanical Technology, Watertown, USA). Participants stand on the force platform in an upright position and on command, perform a maximum height jump with a countermovement and use of arms. Participants perform three attempts, with a 1-min rest between each. The best attempt is evaluated.
12 weeks
Broad jump distance
Time Frame: 12 weeks
The distance in the broad jump is measured with a tape. Participants stand on a pre-marked line with legs approximately shoulder-width apart. From standing, they jump as far forward as possible using a countermovement and land on both feet. The landing spot closest to the starting line is considered for scoring. Participants perform two attempts, with the better attempt being recorded. There is a 1-min rest between attempts.
12 weeks
Unilateral triple jump length
Time Frame: 12 weeks
The length of the unilateral triple jump test is measured with a tape. Participants start on one leg on a pre-marked line. Then using a countermovement from knee flexion, they perform a triple jump with the dominant and subsequently the non-dominant lower limb. After the final jump, they must land on both limbs and maintain their position at the landing spot for at least 2 seconds.
12 weeks

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Linear speed
Time Frame: 12 weeks
A 20-m sprint test is used to assess linear speed. The final time is recorded using photoelectric cells (Brower Timing System, Draper, USA) with accuracy of 0.01 s. Photocells are placed at the start and 20-m mark. Participants start on command, with timing starting as soon as the player begins to move.
12 weeks
Agility test
Time Frame: 12 weeks
For the 505 agility test, photoelectric cells (PR1aW, ALGE-TIMING, Lustenau, Austria) are used, placed at the 10-m mark. Cones are placed at the 0, 10, and 15-m marks. Participants sprint 10 meters and are instructed to reach maximum speed by the 10-m mark. At the 15-m mark, they perform a 180-degree turn and sprint back to the 10-m mark at maximum speed. Each participant have one attempt on the dominant and one attempt on the non-dominant leg for the 180-degree turn.
12 weeks
Reaction test
Time Frame: 12 weeks
In the BlazePod reaction test (Play Coyotta, Tel Aviv, Israel), 5 sensors are placed parallel, 1 m apart from each other. The participant stand 3 m in front of the middle sensor. When any sensor lights up, the participant must press it as quickly as possible and return to the starting position, waiting for the next sensor to light up. Sensors light up in a random order. The test lasts after 10 attempts.
12 weeks
Lower limb stiffness
Time Frame: 12 weeks
Lower limb stiffness is measured using the repeated submaximal jumps test (Optojump Next, Microgate, Italy). Participants perform 20 repeated jumps at a frequency of 2.5 Hz (mechanical metronome Wittner, Isny, Germany). Participants stand approximately shoulder-width apart with their hands on their sides throughout the test. Participants undergo three attempts with 2-min rest in between.
12 weeks
Reactive strength index
Time Frame: 12 weeks
Reactive strength index is measured using the drop jump on AMTI OR6-7-1000 force platform (Advanced Mechanical Technology, Watertown, USA). Participants stand with feet shoulder-width apart on a platform 30 cm above the floor and have their hands on their sides. Then they step off the platform with one foot and upon landing, rebound as quickly as possible and with maximum effort. Reactive strength index is calculated from the ratio of jump height to the duration of contact with the platform.
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Palacky University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Roman Holik, Mgr, Palacky University, Faculty of Physical Culture

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
May 13, 2024

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
August 16, 2024

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
August 16, 2024

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
May 6, 2024

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 6, 2024

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
May 9, 2024

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
June 2, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 29, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
May 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • FTK_2024_10

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Anonymised raw data will be made available.

IPD Sharing Time Frame

The data will be available once the results are published in a scientific journal.

IPD Sharing Access Criteria

For everybody.

Study Data/Documents

  1. Individual Participant Data Set
    Information comments: Holík R, Krejčí J, Lehnert M. Dataset for: "The effect of plyometric training on physical performance in youth soccer players: A randomized controlled trial with maturation status as a covariate". Zenodo; 2025.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings